Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6873311 | 0.81 | ALDH1A1 (0.47) | TSHRNPC1RAB9AALDH1A1 | |
| SCHEMBL6873313 | 0.76 | KMT2A (0.38) | KMT2ANPC1RAB9APOLBL3MBTL1 | |
| SCHEMBL4575280 | 0.76 | TSHR (0.65) | KMT2ATSHRNPC1RAB9AALDH1A1 | |
| SCHEMBL5049189 | 0.74 | L3MBTL1 (0.37) | TSHRL3MBTL1 | |
| SCHEMBL2524010 | 0.74 | POLB (0.54) | ALDH1A1POLBL3MBTL1 | |
| SCHEMBL6873102 | 0.73 | BRD4 (0.47) | KMT2ARAB9A | |
| SCHEMBL6869169 | 0.73 | BRD4 (0.50) | NPC1RAB9AALDH1A1POLBL3MBTL1 | |
| SCHEMBL16058961 | 0.73 | ALDH1A1 (0.35) | KMT2ATSHRNPC1RAB9AALDH1A1 | |
| SCHEMBL16059156 | 0.72 | APEX1 (0.36) | TSHRPOLBL3MBTL1 | |
| SCHEMBL15719844 | 0.70 | POLB (0.35) | KMT2ATSHRRAB9AALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1395560-A1 | 2-OXO-PIPERIDINYL- AND 2-OXO-AZEPANYL ALKANOIC ACID DERIVATIV ES FOR THE TREATMENT OF EPILEPSY AND OTHER NEUROLOGICAL DISORDERS | UCB, S.A. (BE) | 2004-03-10 | — | — | EP | claimed |
| WO-2002094787-A1 | 2-OXO-PIPERIDINYL- AND 2-OXO-AZEPANYL ALKANOIC ACID DERIVATIV ES FOR THE TREATMENT OF EPILEPSY AND OTHER NEUROLOGICAL DISORDERS | UCB, S.A. (BE) | 2002-11-28 | — | — | WO | claimed |
| EP-1395560-A1 | 2-OXO-PIPERIDINYL- AND 2-OXO-AZEPANYL ALKANOIC ACID DERIVATIV ES FOR THE TREATMENT OF EPILEPSY AND OTHER NEUROLOGICAL DISORDERS | UCB, S.A. (BE) | 2004-03-10 | — | — | EP | disclosed |
| WO-2002094787-A1 | 2-OXO-PIPERIDINYL- AND 2-OXO-AZEPANYL ALKANOIC ACID DERIVATIV ES FOR THE TREATMENT OF EPILEPSY AND OTHER NEUROLOGICAL DISORDERS | UCB, S.A. (BE) | 2002-11-28 | — | — | WO | disclosed |